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Background
In our previous experiments a trend to sensitisation to
maternal behavioural disruptive and conditioned place
preference (CPP)-inducing effects of morphine (MO) was
observed when rat dams were treated chronically with a
constant medium dose of MO during pregnancy and lac-
tation. The aim of the present work was to perform more
detailed studies how chronic MO treatment of dams influ-
ences behavioural effects of subsequent MO challenge.
Methods
Pregnant Wistar rats, from the day of mating were treated
daily with MO (10 mg/kg, s.c.) or saline (SAL) until wean-
ing (postpartum day, PD, 21). In both treatment groups
maternal behaviour (active nursing, passive nursing, lit-
tering and behaviours out of the nest) was observed after
an acute challenge with saline, 3 mg/kg naloxone s.c.
(NX), 10 mg/kg MO s.c. and 10 mg/kg MO plus 3 mg/kg
NX s.c. on PD2, PD3, PD5 and PD7, respectively. In a dif-
ferent population of dams, a pup retrieval test was per-
formed after the same challenge. Experiments started 30
min after MO and 10 min after NX injection. In a further
population of MO- and SAL-treated dams, NX aversion
test was made using the place preference paradigm.
Results
(1) Acute challenge with MO significantly impaired the
maternal behaviour in both groups; this effect of MO
could be antagonised completely by NX in the SAL-treated
group, but only partially in the MO-treated one. This
appeared both in observational and pup retrieval tests. (2)
MO treatment significantly potentiated the ability of
naloxone to produce place aversion.
Conclusion
The data indicate that constant medium dose MO treat-
ment during pregnancy and lactation results in sensitisa-
tion to the place aversion-inducing effect of NX similarly
to MO on CPP, but it attenuates the ability of NX to antag-
onise the effect of MO on MB.
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